Specialities

Specialities

Respiratory Infections
Airway Diseases
Allergy
Asthma
Bronchiectasis
Bronchitis
Chronic Cough
COPD
COVID-19
Cystic Fibrosis
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Interventional Pulmonology
Lung Cancer
Paediatric Respiratory Medicine
Respiratory Tract Disorders
Pulmonary Embolism
Pulmonary Hypertension
Respiratory Intensive Care
Rhinosinusitis
Sleep Related Breathing Disorders
Lung Transplantation and Surgery
Ventilation
Lung Health
Rare Diseases
Search

Trending Topic
14 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The Impact of Smart Inhalers on Personalized Asthma Management

Kate Clair Cruden Hughes, Amy Hai Yan Chan

Asthma affects nearly 300 million people worldwide.1 Despite a notable decline in age-standardized prevalence, mortality and disability-adjusted life years over the past three decades, the burden of asthma remains high in many countries including low-middle-income countries.2 Climate change is also predicted to significantly impact asthma and other respiratory-related conditions, as rising global temperatures lead to longer pollen […]

touchREVIEWS in Respiratory & Pulmonary Diseases. 2025;10(1):Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

CME Accredited Learning

Our accredited content is designed to impact patient health outcomes, by ensuring that it provides you with a learning experience that will positively impact your clinical practice, based on adult learning preferences and intuitive instructional design. All activities are developed in collaboration with leading faculty and education partners.

touchRESPIRATORY

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
64 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCONGRESS

Expanding horizons for patients with Pompe disease: Using data to guide clinical practice

Prof. Tahseen Mozaffar, Dr Jennifer L Cohen, Prof. Benedikt Schoser

Leading experts in Pompe disease explore key data from WMS 2024 and WORLDSymposium 2025.

Translations available:
20 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchFOCUS

Focused insights: Data implications of ADCs in NSCLC treatment

Prof. Céline Mascaux

Watch a lung cancer expert discuss the latest data for ADCs in NSCLC and their implications for clinical practice.

99 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCLINICAL PERSPECTIVES

Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease

Dr Helena Yu, Dr Antonio Passaro, Dr Aaron Lisberg, Dr Sara Pilotto, Ms Jackie Fenemore, Prof. Egbert Smit

Experts provide insights on tailoring treatment in patients with EGFR-mutant and wildtype NSCLC.

Translations available:
39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT

Where to next in limited-stage small cell lung cancer? The role of immune checkpoint inhibitors

Dr Lizza Hendriks, Dr Jacob Sands, Prof. Suresh Senan

A multidisciplinary team discusses the role of immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC).

Translations available:
55 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT

Precision targeting of MET in NSCLC: A multidisciplinary approach

Dr Xiuning Le, Dr Christine Argento, Dr Sandra Cuellar, Ms Stephanie McDonald, Prof. Albrecht Stenzinger

A multidisciplinary team of specialists discuss the use of targeted therapies for NSCLC with MET alterations.

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION

Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment

Prof. Jean-Luc Vachiéry, Prof. Manreet Kanwar

Watch two experts discuss the diagnosis, risk stratification and treatment of pulmonary arterial hypertension.

Translations available:
41 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Expanding HER2 horizons: Implications for NSCLC and beyond

Dr Razelle Kurzrock, Dr Lyudmila Bazhenova, Dr Ignacio Wistuba

Two oncologists and a pathologist discuss the implications of HER2 targeting in solid tumours, with a focus on NSCLC.

Translations available:
37 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION

Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies

Prof. Enriqueta Felip, Prof. Keith Kerr

An oncologist and a pathologist discuss HER2 testing and treatments for HER2-altered NSCLC.

Translations available:
33 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS

Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines

Prof. Heather A Wakelee

Prof. Wakelee discusses the latest evidence on immunotherapy for early-stage, resectable NSCLC.

Translations available:

Society & Congress Partners

touchRESPIRATORY is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events

View All
31 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS

Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions

Dr Michael Perch, Dr Howard J Huang, Dr Aldo Iacono

Three experts discuss the pathogenesis, diagnosis and treatment for bronchiolitis obliterans syndrome (BOS).

Translations available:
15 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchFOCUS

Current treatments and unmet needs in limited-stage small cell lung cancer

Dr Anne Chiang

A medical oncologist shares her insights on the current treatments for LS-SCLC and the remaining unmet needs

16 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchFOCUS

Expert insights in food allergy: Considerations for diagnosis and management in primary care and beyond

Dr Antonella Cianferoni

An allergist shares her expert insights on the latest guidance for the diagnosis and management of food allergies, including the role of novel diagnostic tools and emerging therapies in clinical practice.

34 minutes
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchTALKS

Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs

Dr Rebecca Heist

Dr Rebecca Heist discusses emerging antibody-drug conjugates for the second-line treatment of patients with advanced non-small cell lung cancer.

Translations available:
16 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchFOCUS

Addressing the diagnosis and management of pet allergies in primary care and beyond

Dr Ann-Marie Malby Schoos

An allergist shares her expert insights and guidance on key clinical questions around the changing paradigm in the diagnosis and management of pet allergies.

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS

Diagnosing and treating patients with EoE: Tackling the difficulties

Dr Efrem Eren, Dr Nirmala Gonsalves, Dr Jamal Hayat

Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.

Translations available:
18 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchFOCUS

Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy

Dr Balazs Halmos

Dr Balazs Halmos offers his perspective on immunotherapy for the treatment of squamous cell lung cancer.

38 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION

Personalized therapy for NSCLC: Biomarker testing, treatment and management in the presence of MET alterations

Prof. Paul Paik, Dr Yasushi Goto

Two lung cancer specialists discuss the current recommendations for biomarker testing and the latest data on MET inhibitors for the management of patients with MET alterations.

Translations available:
32 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS

The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections

Dr Anna Blakney, Prof. Dr. med. Oliver Cornely, Prof. Ann R Falsey

Leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.

Translations available:
Load More...

All touchIME CME activities are accredited. Learners can claim ACCME, ANCC, ACPE or EBAC credits upon completion of the activities. This content is for healthcare professionals only.

Latest Medical Education - straight to your inbox

Close Popup